IPP Bureau

Twinkle Khanna urges Indian women to check their iron levels
Twinkle Khanna urges Indian women to check their iron levels

By IPP Bureau - February 27, 2024

‘Unmask Anemia’ aims to simplify assessment of iron deficiency anemia risk with an easy online self-test based on common signs and symptoms

Pfizer joins hands with NIPER (Ahmedabad) to support Healthcare Innovation in India
Pfizer joins hands with NIPER (Ahmedabad) to support Healthcare Innovation in India

By IPP Bureau - February 27, 2024

Pfizer INDovation program partners with NIPER Ahmedabad to incubate healthcare startups

Shilpa Medicare gets Europe approval for Varenicline Tablets, 0.5mg and 1mg
Shilpa Medicare gets Europe approval for Varenicline Tablets, 0.5mg and 1mg

By IPP Bureau - February 27, 2024

Varenicline is indicated for smoking cessation in adults

Kilitch Drug India's subsidiary wins tender in Ethiopia
Kilitch Drug India's subsidiary wins tender in Ethiopia

By IPP Bureau - February 27, 2024

The contract awarded to Kilitch Estro Biotech PLC entails the supply of pharmaceuticals with an order size amounting to US$ 9.13 million

Ministry of Ayush and Ministry of Women and Child Development join hands for Nutritional Improvement in adolescent girls through Ayurveda interventions
Ministry of Ayush and Ministry of Women and Child Development join hands for Nutritional Improvement in adolescent girls through Ayurveda interventions

By IPP Bureau - February 27, 2024

Both the Ministries signed MoU for anaemia control among adolescent girls using Ayurveda interventions

VeerHealth Care announces expansion to enhance healthcare solutions
VeerHealth Care announces expansion to enhance healthcare solutions

By IPP Bureau - February 26, 2024

VeerHealth Care will be raising Rs. 8 crores through bank borrowings

Concord Biotech receives GMP certificate from Kenya regulator
Concord Biotech receives GMP certificate from Kenya regulator

By IPP Bureau - February 26, 2024

The said Unit complies with the prescribed Good Manufacturing practices as per relevant WHO technical Report Series

Max Healthcare to acquire land parcel in Lucknow for new hospital
Max Healthcare to acquire land parcel in Lucknow for new hospital

By IPP Bureau - February 26, 2024

The board gave in-principle approval for expansion of company's footprint in Lucknow

Piramal Pharma gets Form 483 with 2 observations from USFDA for Lexington, USA facility
Piramal Pharma gets Form 483 with 2 observations from USFDA for Lexington, USA facility

By IPP Bureau - February 26, 2024

The observations do not pose any risk to site's compliance standards or its business continuity

Zydus receives WHO prequalification for Miltefosine formulation and API
Zydus receives WHO prequalification for Miltefosine formulation and API

By IPP Bureau - February 26, 2024

Leishmaniasis is caused by protozoan parasites which are transmitted by the bite of infected female phlebotomine sandflies

Briefs: Suven Pharmaceuticals, Remedium Lifecare and Kilitch Drugs India
Briefs: Suven Pharmaceuticals, Remedium Lifecare and Kilitch Drugs India

By IPP Bureau - February 24, 2024

Suven Pharmaceuticals’ API and forumulations facilities complete USFDA inspection successfully

India implementing largest digital programme for TB surveillance
India implementing largest digital programme for TB surveillance

By IPP Bureau - February 24, 2024

Experts discussed the latest innovations, challenges, & collaborative solutions in the fight against TB at NHWIC-2024 held at AIIMS, Delhi

Orchid Pharma's 'Exblifep' receives USFDA approval
Orchid Pharma's 'Exblifep' receives USFDA approval

By IPP Bureau - February 24, 2024

Orchid is the first company from India, ever to have invented a product which has received a New Drug Approval (NDA) from USFDA

VP Dhankhar emphasizes need for ethical standards in the medical profession at APICON-2024
VP Dhankhar emphasizes need for ethical standards in the medical profession at APICON-2024

By IPP Bureau - February 24, 2024

The Vice President also highlighted the importance of preventive healthcare and fitness

AstraZeneca completes acquisition of Gracell
AstraZeneca completes acquisition of Gracell

By IPP Bureau - February 23, 2024

The acquisition enriches AstraZeneca’s growing pipeline of cell therapies with GC012F

Latest Stories

Interviews

Packaging